Regulatory data is for reference only. Always verify with the official regulator before making formulation decisions. Last refreshed: 10/12/2026.
Ingredients/Captafol
CaptafolCAS 2425-06-1
EU CosIng II — prohibitedASEAN II — prohibitedChina NMPA — prohibitedUK OPSS — prohibitedBrazil ANVISA — prohibited
Is Captafol restricted in cosmetics?
Captafol is prohibited in EU CosIng, ASEAN, China NMPA, UK OPSS and Brazil ANVISA. Markets not named here hold no entry for it, which is not a clearance.
- CAS
- 2425-06-1
- INCI
- Captafol
- Data refreshed
- 2026-10-12
Regulatory status
| Source | Status | Annex / Details | Limit / Conditions | Last updated |
|---|---|---|---|---|
| EU CosIng | prohibited | Annex II | — | — |
| ASEAN | prohibited | Annex II | — | — |
| China NMPA | prohibited | — | — | 10/7/2026 |
| UK OPSS | prohibited | — | Source: legislation.gov.uk retained EU Regulation 1223/2009 Annex Ii | 10/5/2026 |
| Brazil ANVISA | prohibited | — | — | 10/7/2026 |
What this means
Captafol has regulatory signals in EU CosIng, ASEAN, China NMPA, UK OPSS, Brazil ANVISA. Review the source links above for the official conditions and latest updates.
Recent regulatory changes
No recorded regulatory changes for Captafol yet.
Common questions
- Is Captafol restricted in EU cosmetics?
- Captafol is prohibited in EU cosmetics according to EU CosIng Annex II.
- Is Captafol restricted under the ASEAN Cosmetic Directive?
- Captafol is prohibited under the ASEAN Cosmetic Directive Annex II.
- Is Captafol restricted in China NMPA?
- Captafol is prohibited in cosmetics under China NMPA.
- Is Captafol restricted in UK OPSS?
- Captafol is prohibited in cosmetics under UK OPSS.
- Is Captafol restricted in Brazil ANVISA?
- Captafol is prohibited in cosmetics under Brazil ANVISA.
- What is the CAS number for Captafol?
- The CAS number for Captafol is 2425-06-1.
Check this ingredient in a formula across 11 markets
This page covers one ingredient on its own. Sign up free to check it at your actual concentration, in a full formula, with GHS hazards and per-market verdicts.